Centessa Pharmaceuticals plc - ADR

NASDAQ:CNTA   4:00:00 PM EDT
3.81
+0.03 (+0.79%)
4:49:12 PM EDT: $3.81 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Centessa Pharmaceuticals plc - ADR Stock, NASDAQ:CNTA

1 Ashley Road, 3rd Floor, Altrincham, Cambridgeshire WA14 2DT
United Kingdom
Phone: +44.7391.789784
Number of Employees: 199

Description

Centessa Pharmaceuticals Plc is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. Its portfolio consists of preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. The firm products include Vasopressin V2 Receptor Inhibitor (Lixivaptan), BMP9 Engineered Variant (MGX292), OX2R Agonist (Oral) among others. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.